JP2005097237A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005097237A5 JP2005097237A5 JP2004068255A JP2004068255A JP2005097237A5 JP 2005097237 A5 JP2005097237 A5 JP 2005097237A5 JP 2004068255 A JP2004068255 A JP 2004068255A JP 2004068255 A JP2004068255 A JP 2004068255A JP 2005097237 A5 JP2005097237 A5 JP 2005097237A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- amino acid
- seq
- sequence represented
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 153
- 108090000765 processed proteins & peptides Proteins 0.000 claims 108
- 229920001184 polypeptide Polymers 0.000 claims 86
- 102000004196 processed proteins & peptides Human genes 0.000 claims 86
- 230000001737 promoting effect Effects 0.000 claims 66
- 150000003839 salts Chemical class 0.000 claims 63
- 230000028327 secretion Effects 0.000 claims 45
- 230000027455 binding Effects 0.000 claims 40
- 102000006771 Gonadotropins Human genes 0.000 claims 39
- 108010086677 Gonadotropins Proteins 0.000 claims 39
- 239000002622 gonadotropin Substances 0.000 claims 39
- 102000040430 polynucleotide Human genes 0.000 claims 39
- 108091033319 polynucleotide Proteins 0.000 claims 39
- 239000002157 polynucleotide Substances 0.000 claims 39
- 230000016087 ovulation Effects 0.000 claims 34
- 239000003795 chemical substances by application Substances 0.000 claims 33
- 230000004936 stimulating effect Effects 0.000 claims 32
- 150000001413 amino acids Chemical class 0.000 claims 20
- 102000004169 proteins and genes Human genes 0.000 claims 19
- 108090000623 proteins and genes Proteins 0.000 claims 19
- 210000002149 gonad Anatomy 0.000 claims 13
- 230000002710 gonadal effect Effects 0.000 claims 12
- 239000003112 inhibitor Substances 0.000 claims 10
- 239000003163 gonadal steroid hormone Substances 0.000 claims 8
- 238000012216 screening Methods 0.000 claims 8
- 230000036512 infertility Effects 0.000 claims 5
- 208000000509 infertility Diseases 0.000 claims 5
- 231100000535 infertility Toxicity 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000000032 diagnostic agent Substances 0.000 claims 4
- 229940039227 diagnostic agent Drugs 0.000 claims 4
- 239000005556 hormone Substances 0.000 claims 4
- 229940088597 hormone Drugs 0.000 claims 4
- 201000009273 Endometriosis Diseases 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000011321 prophylaxis Methods 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000035800 maturation Effects 0.000 claims 2
- 230000000580 secretagogue effect Effects 0.000 claims 2
- 230000001568 sexual effect Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 230000035558 fertility Effects 0.000 claims 1
- 230000003325 follicular Effects 0.000 claims 1
- 230000001456 gonadotroph Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000003248 secreting effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004068255A JP4639052B2 (ja) | 2003-03-12 | 2004-03-11 | 性腺機能改善剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003067283 | 2003-03-12 | ||
| JP2003311892 | 2003-09-03 | ||
| JP2004068255A JP4639052B2 (ja) | 2003-03-12 | 2004-03-11 | 性腺機能改善剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005097237A JP2005097237A (ja) | 2005-04-14 |
| JP2005097237A5 true JP2005097237A5 (enExample) | 2007-04-19 |
| JP4639052B2 JP4639052B2 (ja) | 2011-02-23 |
Family
ID=34468253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004068255A Expired - Lifetime JP4639052B2 (ja) | 2003-03-12 | 2004-03-11 | 性腺機能改善剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4639052B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2009131191A1 (ja) * | 2008-04-24 | 2011-08-25 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
| IL265696B2 (en) * | 2016-09-30 | 2024-08-01 | Sumitomo Pharma Switzerland Gmbh | 2-(n-acetyl-d-tyrosyl-trans-4-hydroxy-l-prolyl-l-asparaginyl-l-threonyl-l-phenylalanyl) hydrazinocarbonyl-l-leucyl-nω-methyl-l-arginyl-l-tryptophanamide, for use in assisted reproductive technology. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4486187B2 (ja) * | 1998-10-27 | 2010-06-23 | 武田薬品工業株式会社 | 新規g蛋白質共役型レセプター蛋白質、そのdnaおよびそのリガンド |
| JP2001340094A (ja) * | 2000-03-30 | 2001-12-11 | Takeda Chem Ind Ltd | 新規蛋白質、そのdnaおよびその製造法 |
| JP2003002841A (ja) * | 2001-04-20 | 2003-01-08 | Takeda Chem Ind Ltd | ペプチド含有製剤 |
-
2004
- 2004-03-11 JP JP2004068255A patent/JP4639052B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| George et al. | Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury | |
| JP4026854B2 (ja) | 腸栄養性glp―2ペプチドのアンタゴニスト | |
| JP2025102780A (ja) | 神経ペプチドy受容体の調節因子としての環状ペプチドチロシンチロシン化合物 | |
| US20040052862A1 (en) | Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders | |
| JP2542362B2 (ja) | 新規ハロ低級アルキルグアニジノ置換アミノ酸化合物およびその製法 | |
| JP2009161546A (ja) | グレリン類似体 | |
| EP3212217A1 (en) | Compositions and peptides having dual glp-1r and glp-2r agonist activity | |
| JPS63313800A (ja) | 副甲状腺ホルモン拮抗剤 | |
| KR102117216B1 (ko) | 강력한 작용제 효과를 지닌 신규한 gh-rh 유사체 | |
| JP2005504532A5 (enExample) | ||
| SK12097A3 (en) | Parathormone derivatives and parathormone correlated peptide, preparation method thereof and pharmaceutical composition containing them | |
| KR101345253B1 (ko) | 하나 이상의 합성 아미노산 치환을 가지는 뉴로펩타이드 y 유사체 | |
| JP2002533115A5 (enExample) | ||
| JP2005097237A5 (enExample) | ||
| JP2006507229A5 (enExample) | ||
| WO1994007519A1 (en) | Growth hormone releasing peptides | |
| JP2014515751A (ja) | 成長ホルモン放出因子(grf)類似体およびその使用 | |
| JP2005514010A5 (enExample) | ||
| JP2014505680A (ja) | 環状crfアンタゴニストペプチド及びその薬学的に許容される塩 | |
| Haramura et al. | Design and synthesis of N-terminal cyclic motilin partial peptides: a novel pure motilin antagonist | |
| JP2004292444A5 (enExample) | ||
| JP2004049003A5 (enExample) | ||
| RU2021100770A (ru) | Неоантигены и их применение | |
| Berglund et al. | Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5 | |
| EA047394B1 (ru) | Агонисты рецептора npy2 |